MLN4924 HCl Salt: Precision NEDD8-Activating Enzyme Inhib...
MLN4924 HCl Salt: Precision NEDD8-Activating Enzyme Inhibition in Cancer and Viral Research
Executive Summary: MLN4924 HCl salt (SKU A3629) is a highly specific NEDD8-activating enzyme (NAE) inhibitor, widely used to disrupt the neddylation pathway in preclinical research (APExBIO, product page). By blocking NAE, MLN4924 leads to cullin-RING ligase (CRL) inhibition, resulting in protein ubiquitination disruption, cell cycle arrest, and apoptosis induction in tumor models (Liu et al., 2021). The compound is soluble in DMSO, with recommended storage at -20°C for stability. MLN4924’s utility extends into studies of viral pathogenesis, where neddylation and ubiquitination control host-pathogen interactions. This article provides atomic, evidence-based guidance for adopting MLN4924 HCl salt in advanced cancer and virology workflows.
Biological Rationale
The neddylation pathway is essential for activating cullin-RING ligases (CRLs), which regulate protein degradation via ubiquitination. Disrupting neddylation with a small molecule NAE inhibitor like MLN4924 HCl salt halts CRL-mediated protein turnover. This leads to accumulation of CRL substrates, induction of cell cycle arrest, and apoptosis, particularly in rapidly dividing cells (Liu et al., 2021). Viral pathogens, such as orthopoxviruses, exploit or disrupt this pathway to evade host immune responses and modulate cell death programs. Targeting neddylation is thus a validated strategy in cancer biology research and investigations of viral pathogenesis (MLN4924 HCl Salt: Scenario-Driven Solutions – this article extends previous findings by detailing mechanistic evidence and workflows).
Mechanism of Action of MLN4924 HCl Salt
MLN4924 HCl salt is chemically described as [(1S,2S,4R)-4-[4-[[(1S)-2,3-dihydro-1H-inden-1-yl]amino]pyrrolo[2,3-d]pyrimidin-7-yl]-2-hydroxycyclopentyl]methyl sulfamate hydrochloride (molecular weight: 479.98; CAS: 1160295-21-5). As a tight-binding, selective inhibitor, MLN4924 blocks the enzymatic activity of NEDD8-activating enzyme (NAE). NAE catalyzes the first step in the conjugation of NEDD8 to cullin proteins, a modification necessary for CRL E3 ligase activation. Inhibition of NAE by MLN4924 prevents cullin neddylation, resulting in the inactivation of CRLs.
This disruption leads to the accumulation of CRL substrates (e.g., cell cycle regulators such as p27Kip1, CDT1, and others), causing cell cycle arrest (commonly at the G2/M phase) and apoptosis (Liu et al., 2021). The compound is soluble in DMSO and exhibits high stability when stored at -20°C, but solutions should be freshly prepared prior to use (APExBIO product page).
Evidence & Benchmarks
- MLN4924 HCl salt exhibits nanomolar potency against NAE (IC50 < 5 nM, in vitro enzymatic assay at 25°C, pH 7.5) (Liu et al., 2021).
- Treatment of cancer cell lines (e.g., HCT116, U2OS) with 0.1–1 μM MLN4924 for 24–48 hours leads to dose-dependent accumulation of CRL substrates and G2/M phase arrest (Liu et al., 2021).
- MLN4924-induced CRL inhibition triggers apoptosis, as measured by caspase-3 cleavage and Annexin V staining, in various tumor models (Benchmarking NEDD8-Activating Enzyme Inhibitors – this article provides updated quantitative benchmarks under defined conditions).
- In viral infection models, CRL modulation by neddylation inhibitors alters the degradation of host proteins involved in innate immunity, impacting viral replication and inflammation (Liu et al., 2021).
- MLN4924 is not cytotoxic to non-dividing cells at concentrations up to 10 μM for <48 hours, highlighting selectivity for proliferating cells (Practical Solutions for Cell Viability – this article is extended with mechanistic specificity and negative controls).
Applications, Limits & Misconceptions
Applications:
- Cancer biology research: Used to induce cell cycle arrest and apoptosis in cancer cell lines via CRL inhibition.
- Protein ubiquitination research: Enables precise study of neddylation-dependent proteostasis and substrate turnover.
- Anticancer drug development: Serves as a benchmark compound in preclinical screening and mechanistic evaluation.
- Virus-host interaction studies: Investigates the role of neddylation in viral immune evasion and host cell death pathways (Unveiling Neddylation Inhibition in Virus-Induced Inflammation – this article adds translational and application-level detail).
Common Pitfalls or Misconceptions
- MLN4924 HCl salt is not a pan-ubiquitination inhibitor; it specifically targets neddylation via NAE inhibition.
- It is not suitable for in vivo diagnostic or therapeutic use; intended strictly for research (APExBIO).
- Long-term stock solutions in DMSO lose activity; always prepare solutions fresh before each experiment.
- Non-proliferating cells show limited response; assays must include proliferative controls for accurate interpretation.
- Off-target effects may occur at >10 μM; use validated concentrations and controls to ensure specificity.
Workflow Integration & Parameters
MLN4924 HCl salt is supplied by APExBIO in a stable, crystalline form. For in vitro assays, dissolve in DMSO to a stock concentration of 10 mM. Recommended working concentrations range from 0.01 μM to 10 μM, depending on cell type and endpoint. Always store the powder at -20°C and avoid repeated freeze-thaw cycles. For protein ubiquitination and cell cycle studies, treat cells for 24–48 hours, monitor substrate accumulation (e.g., by western blot for p27Kip1), and measure cell viability or apoptosis as appropriate. Refer to scenario-driven guidance in MLN4924 HCl Salt: Scenario-Driven Solutions for troubleshooting and optimization. For advanced applications in viral pathogenesis, consult Unveiling Neddylation Inhibition in Virus-Induced Inflammation for detailed protocols and context contrasts.
Conclusion & Outlook
MLN4924 HCl salt (A3629) is a gold-standard small molecule NAE inhibitor for dissecting the neddylation pathway’s role in cancer biology and viral immunology. Its atomic precision and selectivity enable reproducible, mechanistic insights into cell cycle and apoptosis regulation. Future research will continue to refine its translational potential and expand its application in studying pathogen-host interactions. For further details, see the MLN4924 HCl salt product page and linked benchmark studies.